Pathophysiological consequences of obstructive jaundice and perioperative management

Poduri CD. Jaundice: a brief historical perspective. Apollo Med 2014;13:76–79. Lucas WB, Chuttani R. Pathophysiology and current concepts in the diagnosis of obstructive jaundice. Gastroenterologist 1995;3:105–118. Wang L, Yu WF. Obstructive jaundice and perioperative management. Acta Anaesthesiol Taiwan 2014;52:22–29. Briggs CD, Peterson M. Investigation and management of obstructive Jaundice. Surgery (Oxford) 2007;25:74–80. Kinney TP. Management of ascending cholangitis. Gastrointest Endosc Clin N Am 2007;17: 289–306, vi. Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreatic Surg 2007;14:15–26. Ramappa V, Aithal GP. Jaundice: applying lessons from physiology. Surgery (Oxford) 2009;27:11–18. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol 2003;9:385–391. Bassari R, Koea JB. Jaundice associated pruritis: a review of pathophysiology and treatment. World J Gastroenterol 2015;21:1404–1413. Fukushima S, Okuno H, Shibatani N, Nakahashi Y, Seki T, Okazaki K. Effect of biliary obstruction and internal biliary drainage on hepatic cytochrome P450 isozymes in rats. World J Gastroenterol 2008;14:2556–2560. Padillo F, Rodríguez Mf, Hervas A, Miño G, Sitges-Serra A, Pera-Madrazo C. Nutritional assessment of patients with benign and malignant obstructions of the biliary tract. Rev Esp Enferm Dig 1999;91:622–629. Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, et al. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis 2014;19:30–41. Lalisang TJ, Sjamsuhidajat R, Siregar NC, Taher A. Profile of hepatocyte apoptosis and bile lakes before and after bile duct decompression in severe obstructive jaundice patients. Hepatobiliary Pancreatic Dis Int 2010;9:520–523. Lv X, Song JG, Li HH, Ao JP, Zhang P, Li YS, et al. Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice. World J Gastroenterol 2011;17:5267–5273. Alturfan AA, Aytaç E, Emekli-Alturfan E, Yarat A, Sarıbeyoğlu K, Pekmezci S, et al. Serum total sialic acid as a novel complementary candidate marker of hepatic damage in obstructive jaundice. Ann Clin Lab Sci 2014;44:56–61. Yashima Y, Tsujino T, Masuzaki R, Nakai Y, Hirano K, Tateishi R, et al. Increased liver elasticity in patients with biliary obstruction. J Gastroenterol 2011;46:86–91. Clements WD, McCaigue M, Erwin P, Halliday I, Rowlands BJ. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996;38:925–931. Okaya T, Nakagawa K, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, et al. The alterations in hepatic microcirculation and Kupffer cell activity after biliary drainage in jaundiced mice. J Hepatobiliary Pancreatic Sci 2012;19:397–404. Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol 2007;13:6458–6464. Assimakopoulos SF, Tsamandas AC, Louvros E, Vagianos CE, Nikolopoulou VN, Thomopoulos KC, et al. Intestinal epithelial cell proliferation, apoptosis and expression of tight junction proteins in patients with obstructive jaundice. Eur J Clin Invest 2011;41:117–125. Assimakopoulos SF, Vagianos CE, Charonis AS, Alexandris IH, Spiliopoulou I, Thomopoulos KC, et al. Experimental obstructive jaundice alters claudin-4 expression in intestinal mucosa: effect of bombesin and neurotensin. World J Gastroenterol 2006;12:3410–3415. Jones C, Badger SA, Regan M, Clements BW, Diamond T, Parks RW, et al. Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v. Eur J Gastroenterol Hepatol 2013;25:1424–1430. Koutelidakis I, Papaziogas B, Giamarellos-Bourboulis EJ, Makris J, Pavlidis T, Giamarellou H, et al. Systemic endotoxaemia following obstructive jaundice: the role of lactulose. J Surg Res 2003;113:243–247. Deitch EA, Sittig K, Li M, Berg R, Specian RD. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 1990;159:79–84. Ingoldby CJ, McPherson GA, Blumgart LH. Endotoxemia in human obstructive jaundice. Effect of polymyxin B. Am J Surg 1984;147:766–771. Reynolds JV. Gut barrier function in the surgical patient. Br J Surg 1996;83:1668–1669. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 1994;57:316–336. Lu Y, Zhang BY, Zhao C, Jin X. Effect of obstructive jaundice on hemodynamics in the liver and its clinical significance. Hepatobiliary Pancreatic Dis Int 2009;8:494–497. Sitges-Serra A, Carulla X, Piera C, Martínez-Ródenas F, Franch G, Pereira J, et al. Body water compartments in patients with obstructive jaundice. Br J Surg 1992;79:553–556. Padillo J, Puente J, Gómez M, Dios F, Naranjo A, Vallejo JA, et al. Improved cardiac function in patients with obstructive jaundice after internal biliary drainage: hemodynamic and hormonal assessment. Ann Surg 2001;234:652–656. Fogarty BJ, Parks RW, Rowlands BJ, Diamond T. Renal dysfunction in obstructive jaundice. Br J Surg 1995;82:877–884. Pain JA, Cahill CJ, Gilbert JM, Johnson CD, Trapnell JE, Bailey ME. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose. Br J Surg 1991;78:467–469. Uslu A, Cayci M, Nart A, Karaca C, Zalluhoglu N, Gürkan A, et al. Renal failure in obstructive jaundice. Hepatogastroenterology 2005;52:52–54. Naranjo A, Cruz A, López P, Chicano M, Martín-Malo A, Sitges-Serra A, et al. Renal function after dopamine and fluid administration in patients with malignant obstructive jaundice. A prospective randomized study. J Gastrointest Liver Dis 2011;20:161–167. Uslu A, Taşli FA, Nart A, Postaci H, Aykas A, Bati H, et al. Human kidney histopathology in acute obstructive jaundice: a prospective study. Eur J Gastroenterol Hepatol 2010;22:1458–1465. Nehéz L, Andersson R. Compromise of immune function in obstructive jaundice. Eur J Surg 2002;168:315–328. Parlesak A, Schaeckeler S, Moser L, Bode C. Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production. Crit Care Med 2007;35:2367–2374. Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Gouma DJ. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg 1995;181:567–581. Chowdhury AH, Camara M, Martinez-Pomares L, Zaitoun AM, Eremin O, Aithal GP, et al. Immune dysfunction in patients with obstructive jaundice before and after endoscopic retrograde cholangiopancreatography. Clin Sci (Lond) 2016;130:1535–1544. Hunt DR, Allison ME, Prentice CR, Blumgart LH. Endotoxemia, disturbance of coagulation, and obstructive jaundice. Am J Surg 1982;144:325–329. Papadopoulos V, Filippou D, Manolis E, Mimidis K. Haemostasis impairment in patients with obstructive jaundice. J Gastrointest Liver Dis 2007;16:177–186. Armstrong CP, Dixon JM, Duffy SW, Elton RA, Davies GC. Wound healing in obstructive jaundice. Br J Surg 1984;71:267-270. Junejo MA, Siriwardena AK, Parker MJ. Peripheral oxygen extraction in patients with malignant obstructive jaundice. Anaesthesia 2014;69:32–36. Song JG, Cao YF, Sun YM, Ge YH, Xu XW, Yang LQ, et al. Baroreflex sensitivity is impaired in patients with obstructive jaundice. Anesthesiology 2009;111:561–565. Uslu A, Nart A, Colak T, Aykas A, Yüzbasioglu MF, Hidir K, et al. Predictors of mortality and morbidity in acute obstructive jaundice: implication of preventive measures. Hepatogastroenterology 2007;54:1331–1334. Diamond T, Parks RW. Perioperative management of obstructive jaundice. Br J Surg 1997;84:147–149. Hatipoglu S, Yildiz H, Bulbuloglu E, Coskuner I, Kurutas EB, Hatipoglu F, et al. Protective effects of intravenous anesthetics on kidney tissue in obstructive jaundice. World J Gastroenterol 2014;20:3320–3326. Zhou YK, Qin HL, Zhang M, Shen TY, Chen HQ, Ma YL, et al. Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice. World J Gastroenterol 2012;18:3977–3991. Wang ZK, Xiao JG, Huang XF, Gong YC, Li W. Effect of biliary drainage on inducible nitric oxide synthase, CD14 and TGR5 expression in obstructive jaundice rats. World J Gastroenterol 2013;19:2319–2330. Moole H, Bechtold M, Puli SR. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol 2016;14:182. Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, et al. Meta-analysis of randomized clinical trials on safety and efficacy of biliary drainage before surgery for obstructive jaundice. Br J Surg 2013;100:1589–1596. Su Z, Koga R, Saiura A, Natori T, Yamaguchi T, Yamamoto J. Factors influencing infectious complications after pancreatoduodenectomy. J Hepatobiliary Pancreatic Sci 2010;17:174–179. Moghimi M, Marashi SA, Salehian MT, Sheikhvatan M. Obstructive jaundice in Iran: factors affecting early outcome. Hepatobiliary Pancreatic Dis Int 2008;7:515–519. Pitiakoudis M, Mimidis K, Tsaroucha AK, Papadopoulos V, Karayiannakis A, Simopoulos C. Predictive value of risk factors in patients with obstructive jaundice. J Int Med Res 2004;32:633–638. Lai EC, Lau SH, Lau WY. The current status of preoperative biliary drainage for patients who receive pancreaticoduodenectomy for periampullary carcinoma: a comprehensive review. Surgeon 2014;12:290–296. Sugiyama H, Tsuyuguchi T, Sakai Y, Mikata R, Yasui S, Watanabe Y, et al. Current status of preoperative drainage for distal biliary obstruction. World J Hepatol 2015;7:2171–2176. de Bellis M, PR, Sandomenico C, Di Girolamo E, Cascella M, Fiore F. Is preoperative endoscopic biliary drainage indicated for jaundiced patients with respectable pancreatic cancer? Curr Drug Targets 2012;13:753–763. Xiong JJ, Nunes QM, Huang W, Pathak S, Wei AL, Tan CL, et al. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol 2013;19:8731–8739. Paik WH, Loganathan N, Hwang JH. Preoperative biliary drainage in hilar cholangiocarcinoma: When and how? World J Gastrointest Endosc 2014;6:68–73. Hameed A, Pang T, Chiou J, Pleass H, Lam V, Hollands M, et al. Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma—a systematic review and meta-analysis. HPB (Oxford) 2016;18:400–410. Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 2013;100:274–283. Shimizu H, Kato A, Takayashiki T, Kuboki S, Ohtsuka M, Yoshitomi H, et al. Peripheral portal vein-oriented non-dilated bile duct puncture for percutaneous transhepatic biliary drainage. World J Gastroenterol 2015;21:12628–12634. Ogura T, Higuchi K. Does endoscopic ultrasound-guided biliary drainage really have clinical impact? World J Gastroenterol 2015;21:1049–1052.